Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Journal: The Medical letter on drugs and therapeutics
Published: October 08, 2025

INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema.

INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema.

Journal: Journal of drugs in dermatology : JDD
Published: October 02, 2025

A case of rhododendrol-induced leukoderma successfully treated with topical delgocitinib and UVA1 phototherapy.

A case of rhododendrol-induced leukoderma successfully treated with topical delgocitinib and UVA1 phototherapy.

Journal: European journal of dermatology : EJD
Published: September 18, 2025

When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczema.

When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczema.

Journal: JAAD international
Published: August 20, 2025

Chronic hand eczema treatment with topical delgocitinib cream.

Chronic hand eczema treatment with topical delgocitinib cream.

Journal: Clinical and experimental dermatology
Published: August 15, 2025

Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.

Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.

Journal: American journal of clinical dermatology
Published: July 23, 2025

Reply to 'Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema'.

Reply to 'Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema'.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 17, 2025

Targeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics.

Targeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics.

Journal: Current issues in molecular biology
Published: July 07, 2025

Response to Gooderham et al.'s "Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials."

Response to Gooderham et al.'s "Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials."

Journal: Journal of the American Academy of Dermatology
Published: July 07, 2025

Delayed absorption and systemic variability of topical delgocitinib in chronic hand eczema.

Delayed absorption and systemic variability of topical delgocitinib in chronic hand eczema.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 20, 2025

Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema.

Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema.

Journal: Drugs
Published: June 18, 2025

Stereoselective Synthesis of Delgocitinib and Its Diastereomer Using Organocatalyzed Michael Addition.

Stereoselective Synthesis of Delgocitinib and Its Diastereomer Using Organocatalyzed Michael Addition.

Journal: Organic letters
Published: June 14, 2025
Showing 1-12 of 120

Last Updated: 10/31/2025